US FDA Flags Shortage of Neurosurgical Pads and Sponges, Expects Disruption Through 2026
The agency said the shortage could last through year-end after Medline recalled neuro sponge products over higher-than-expected endotoxin levels.
7 Articles
7 Articles
FDA announces shortage of products used for neurosurgery, microsurgery expected to continue remainder of 2026
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, and expects the issue to continue through the end of the year. The agency said a manufacturing disruption in supplying the products is expected to impact patient care and could require adjustments to clinical management of patients receiving neurosurgery or microsurgery. The F…
The U.S. Food and Drug Administration has warned that there is a persistent supply shortage in the market for sterile neurosurgical devices, which could last until the end of 2026.
FDA Reports on Disruptions in Availability of Neurosurgical Patties, Sponges & Strips
Today, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers to notify providers that we are aware that the United States is experiencing interruptions in the supply of neurosurgical patties, sponges and strip devices because of recent supplier issues. The FDA also updated the medical device shortage list to include neurosurgical patties, sponges and strip devices (product code HBA). The disruption in availability…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
